The mitophagy inhibitor Ac220 enhances the inhibitory effect of magnolol on the malignant phenotype of SK-ES-1 ES cells

Ewing sarcoma (ES) is a highly malignant bone and soft tissue tumor, and its clinical treatment faces challenges such as drug resistance and recurrence. Magnolol, a natural antitumor compound, can inhibit tumor growth through multi-target effects, but its efficacy as a monotherapy is limited, and high doses may be associated with toxicity. This study investigated the mechanism of magnolol in SK-ES-1 ES cells and evaluated the combination effect of the mitophagy inhibitor Ac220. The impact of magnolol on mitochondrial function and autophagy was analyzed using JC-1 staining, ATP assays, Western blotting, transmission electron microscopy (TEM), and a dual-fluorescence autophagy reporter system (mCherry-GFP-LC3B). The results demonstrated that magnolol dose-dependently induced mitochondrial membrane potential depolarization, reduced ATP production, and degraded mitochondrial structural proteins, with associated upregulation of PINK1 and Parkin. Further studies revealed that Ac220 modulated the PINK1/Parkin pathway, thereby affecting magnolol-induced autophagy-related mitochondrial turnover. Combination experiments showed that Ac220 significantly enhanced magnolol’s inhibitory effects on SK-ES-1 cell proliferation, colony formation, and apoptosis. Furthermore, genetic knockdown of PINK1 mimicked the effect of Ac220, potentiating magnolol-induced cytotoxicity and suggesting a role for the PINK1/Parkin pathway in this process. In vivo xenograft models confirmed that the combination therapy group exhibited significantly reduced tumor volume and weight compared to monotherapy groups. These findings suggest that, in SK-ES-1 cells, magnolol induces mitochondrial dysfunction accompanied by autophagy-related changes involving PINK1/Parkin, and that Ac220 may enhance magnolol’s effects by interfering with this process, offering a potential combination strategy for further investigation in ES.

Authors

Institutions

Publication Details

Journal
Cell Division
Published
2026-11-18
DOI
https://doi.org/10.1186/s13008-026-00199-9
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The mitophagy inhibitor Ac220 enhances the inhibitory effect of magnolol on the malignant phenotype of SK-ES-1 ES cells

Xiangyue Wang, Yue Xiu, Tian Gao, Chenglun Yao
1 links
Cell Division
Autophagy in Disease and Therapy
article

The mitophagy inhibitor Ac220 enhances the inhibitory effect of magnolol on the malignant phenotype of SK-ES-1 ES cells

Xiangyue Wang, Yue Xiu, Tian Gao, Chenglun Yao
article en

Abstract

Ewing sarcoma (ES) is a highly malignant bone and soft tissue tumor, and its clinical treatment faces challenges such as drug resistance and recurrence. Magnolol, a natural antitumor compound, can inhibit tumor growth through multi-target effects, but its efficacy as a monotherapy is limited, and high doses may be associated with toxicity. This study investigated the mechanism of magnolol in SK-ES-1 ES cells and evaluated the combination effect of the mitophagy inhibitor Ac220. The impact of magnolol on mitochondrial function and autophagy was analyzed using JC-1 staining, ATP assays, Western blotting, transmission electron microscopy (TEM), and a dual-fluorescence autophagy reporter system (mCherry-GFP-LC3B). The results demonstrated that magnolol dose-dependently induced mitochondrial membrane potential depolarization, reduced ATP production, and degraded mitochondrial structural proteins, with associated upregulation of PINK1 and Parkin. Further studies revealed that Ac220 modulated the PINK1/Parkin pathway, thereby affecting magnolol-induced autophagy-related mitochondrial turnover. Combination experiments showed that Ac220 significantly enhanced magnolol’s inhibitory effects on SK-ES-1 cell proliferation, colony formation, and apoptosis. Furthermore, genetic knockdown of PINK1 mimicked the effect of Ac220, potentiating magnolol-induced cytotoxicity and suggesting a role for the PINK1/Parkin pathway in this process. In vivo xenograft models confirmed that the combination therapy group exhibited significantly reduced tumor volume and weight compared to monotherapy groups. These findings suggest that, in SK-ES-1 cells, magnolol induces mitochondrial dysfunction accompanied by autophagy-related changes involving PINK1/Parkin, and that Ac220 may enhance magnolol’s effects by interfering with this process, offering a potential combination strategy for further investigation in ES.

Cell Division
Jiaxing University (CN), First Hospital of Jiaxing (CN)
Zhejiang Traditional Chinese Medicine Administration
Good health and well-being
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon